Jan Geissler
@jangeissler
Patient activist and research patient advocate. Life is precious.
ID: 35566529
http://www.patvocates.net/jangeissler 26-04-2009 21:12:57
3,3K Tweet
2,2K Followers
520 Following
Interesting presentation of Andreas Hochhaus at #ASH23 about 8 year Asciminib data of phase-I study of Asciminib. With median treatment of -6yrs, only 13% patients discontinued due to AEs. No increased risk of AEs with longer exposure, no new safety signals